RESMED INC — Director's Dealing 2012

Nov 19, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-11-15

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-15	ResMed Common Stock	S	33640	$39.00	Disposed	110936.281	Direct
2012-11-16	ResMed Common Stock	S	51662	$38.933	Disposed	59274.281	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-11-15	ResMed Stock Options	$38.98	A	33714	Acquired	2019-11-15	ResMed Common Stock (33714)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $38.80 to $39.02. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F2: Represents date options first become exercisable. Options will vest 1/3 annually on 11/11/2013, 11/11/2014 and 11/11/2015.